The role of hemoglobin concentration in clinically localized prostate cancer treated with radical radiotherapy +/- neoadjuvant androgen deprivation

By Parker C.   Warde P.   Norman A.   Panzarella T.   Catton C.   Horwich A.   Huddart R.   Dearnaley D.  

International Journal of Radiation Oncology*Biology*Physics, Vol. 58, Iss. 1, 2004-01 ,pp. : 53-58

Elsevier

Access to resources Recommend Favorite

15-year prospective follow-up of patient-reported outcomes of late bowel toxicity after external beam radiotherapy for localized prostate cancer. A comparison with age-matched controls

By Fransson Per   Widmark Anders  

Acta Oncologica, Vol. 46, Iss. 4, 2007-01 ,pp. : 517-524

Informa Healthcare

Access to resources Recommend Favorite

Prospective evaluation of fatigue during a course of curative radiotherapy for localised prostate cancer

By Danjoux Cyril  

Supportive Care in Cancer, Vol. 15, Iss. 10, 2007-10 ,pp. : 1169-1176

Springer Publishing Company

Access to resources Recommend Favorite

Living alone, obesity and smoking: Important factors for quality of life after radiotherapy and androgen deprivation therapy for prostate cancer

By Dieperink Karin B.   Hansen Steinbjørn   Wagner Lis   Johansen Christoffer   Andersen Klaus K.   Hansen Olfred  

Acta Oncologica, Vol. 51, Iss. 6, 2012-07 ,pp. : 722-729

Informa Healthcare

Access to resources Recommend Favorite

Androgen deprivation and high-dose radiotherapy for oligometastatic prostate cancer patients with less than five regional and/or distant metastases

By Schick Ulrike   Jorcano Sandra   Nouet Philippe   Rouzaud Michel   Vees Hansjoerg   Zilli Thomas   Ratib Osman   Weber Damien C.   Miralbell Raymond  

Acta Oncologica, Vol. 52, Iss. 8, 2013-11 ,pp. : 1622-1628

Informa Healthcare

Access to resources Recommend Favorite